A major challenge in epilepsy research is to unravel the complex genetic mechanisms underlying both common and rare forms of epilepsy, as well as the genetic determinants of response to treatment. To accelerate progress in this area, the National Institute of Neurological Disorders and Stroke (NINDS) recently offered funding for the creation of a “Center without Walls” to focus on the genetics of human epilepsy. This article describes Epi4K, the collaborative study supported through this grant mechanism and having the aim of analyzing the genomes of a minimum 4,000 subjects with highly selected and well‐characterized epilepsy
Genetic and molecular biological methodologies are being applied to the study of patients with epile...
John C Mulley1,2, Leanne M Dibbens31Department of Genetic Medicine, Directorate of Genetics and Mole...
In the September 12, 2013 issue of Nature, the Epi4K Consortium (Allen et al., 2013) reported sequen...
A major challenge in epilepsy research is to unravel the complex genetic mechanisms underlying both ...
Fulltext embargoed for: 12 months post date of publicationA major challenge in epilepsy research is ...
Understanding the aetiology of epilepsy is essential both for clinical management of patients and fo...
The epilepsies affect around 65 million people worldwide and have a substantial missing heritability...
Background: The advent of Next Generation Sequencing (NGS) has led to a redefining of the genetic l...
The epilepsies affect around 65 million people worldwide and have a substantial missing heritability...
The approach to epilepsy care has transformed in the last 30 years, with more and better anti-epilep...
BackgroundEpilepsy is a common neurological disorder that affects approximately 50 million people wo...
Epilepsy is one of the most common neurological disorder, affecting 5–8/1.000 individuals worldwide....
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
Genetic and molecular biological methodologies are being applied to the study of patients with epile...
John C Mulley1,2, Leanne M Dibbens31Department of Genetic Medicine, Directorate of Genetics and Mole...
In the September 12, 2013 issue of Nature, the Epi4K Consortium (Allen et al., 2013) reported sequen...
A major challenge in epilepsy research is to unravel the complex genetic mechanisms underlying both ...
Fulltext embargoed for: 12 months post date of publicationA major challenge in epilepsy research is ...
Understanding the aetiology of epilepsy is essential both for clinical management of patients and fo...
The epilepsies affect around 65 million people worldwide and have a substantial missing heritability...
Background: The advent of Next Generation Sequencing (NGS) has led to a redefining of the genetic l...
The epilepsies affect around 65 million people worldwide and have a substantial missing heritability...
The approach to epilepsy care has transformed in the last 30 years, with more and better anti-epilep...
BackgroundEpilepsy is a common neurological disorder that affects approximately 50 million people wo...
Epilepsy is one of the most common neurological disorder, affecting 5–8/1.000 individuals worldwide....
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
Genetic and molecular biological methodologies are being applied to the study of patients with epile...
John C Mulley1,2, Leanne M Dibbens31Department of Genetic Medicine, Directorate of Genetics and Mole...
In the September 12, 2013 issue of Nature, the Epi4K Consortium (Allen et al., 2013) reported sequen...